Nvidia (NVDA) receives an upgrade from Summit Research, which points to strong fiscal Q4 results and the company’s focus on tokenomics optimization as key drivers. Novo Nordisk (NVO) also sees an upgrade to Hold from KM Capital, though
SA analyst upgrades/downgrades: NVDA, NKE, SMCI, NVO
